title: Successful treatment with dabrafenib (GSK2118436) in a patient with ganglioglioma.
authors: Sarah Cannon Research Institute; Tennessee Oncology; and St Thomas Hospital, Nashville, TN kshih@tnonc.com.
authors: Kent C
authors: KC
authors: Shih
authors: Sarah Cannon Research Institute, Nashville, TN.
authors: Mythili
authors: M
authors: Shastry
authors: St Thomas Hospital, Nashville, TN.
authors: Jeffrey T
authors: JT
authors: Williams
authors: St Thomas Hospital, Nashville, TN.
authors: Peter F
authors: PF
authors: Jelsma
authors: St Thomas Hospital, Nashville, TN.
authors: Steven R
authors: SR
authors: Abram
authors: Kosair Children's Hospital, University of Louisville, Louisville, KY.
authors: Kanyalakshmi
authors: K
authors: Ayyanar
authors: Sarah Cannon Research Institute; and Tennessee Oncology, Nashville, TN.
authors: Howard A
authors: HA
authors: Burris
authors: Sarah Cannon Research Institute; and Tennessee Oncology, Nashville, TN.
authors: Jeffrey R
authors: JR
authors: Infante
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018303:Ganglioglioma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D010091:Oximes / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D010091:Oximes; C561627:dabrafenib